Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC.
Hosui A, Hayata N, Kurahashi T, Namiki A, Okamoto A, Aochi K, Ashida M, Tanimoto T, Murai H, Ohnishi K, Hirao M, Yamada T, Hiramatsu N.
Hosui A, et al. Among authors: ohnishi k.
Cancers (Basel). 2025 Jan 8;17(2):185. doi: 10.3390/cancers17020185.
Cancers (Basel). 2025.
PMID: 39857967